공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

정형외과용 기기 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년)

Orthopedic Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2021년 03월 상품 코드 390850
페이지 정보 영문
US $ 4,250 ₩ 4,793,000 PDF (Single User License)
US $ 4,750 ₩ 5,357,000 PDF (Team License: Up to 7 Users)
US $ 6,000 ₩ 6,766,000 PDF (Site License)
US $ 7,500 ₩ 8,458,000 PDF (Corporate License)

정형외과용 기기 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년) Orthopedic Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
발행일 : 2021년 03월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 정형외과용 기기(Orthopedic Devices) 시장에 대해 조사했으며, 전체적인 시장 동향, 용도·지역별 동향, 시장 성장에 대한 영향요인 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 전해드립니다.


제1장 서론

  • 시장 정의

제2장 조사 방법

제3장 주요 요약

제4장 주요 영향요인

제5장 시장 개요

  • 현재 시장 시나리오
  • Porter's Five Forces 분석
    • 공급업체의 협상력
    • 소비자의 협상력
    • 신규 참여업체의 위협
    • 대체 제품 및 서비스의 위협
    • 업계내에서의 경쟁

제6장 성장 촉진요인, 성장 저해요인, 기회, 과제 분석(DROC)

  • 시장 성장 촉진요인
    • 대규모 관절 재건 수술 증가
    • 노령 인구 증가에 의한 정형외과 질환의 유병률 상승
    • 생체흡수성 티타늄 임플란트의 개발
    • 정형외과 임플란트 수요 고조
  • 시장 성장 저해요인
    • 엄격한 규제 개혁
    • 조직 공학 및 신약 개발 등의 대체 방법
  • 시장 기회
  • 주요 과제

제7장 시장 세분화

  • 용도별
    • 고관절 정형외과용 기기
    • 관절 재건
    • 슬관절 정형외과용 기기
    • 척추 정형외과용 기기
    • 외상 고정 기기
    • 두개악안면(CMF) 정형외과용 기기
    • 치과 정형외과용 기기
    • 기타
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 중동 및 아프리카
    • 남미

제8장 경쟁 상황

  • M&A 분석
  • 합의, 협업, 파트너십
  • 신제품 발매

제9장 주요 기업

  • DePuy Synthes Companies
  • DJO Global Inc.
  • Globus Medical Inc.
  • Integra LifeSciences
  • Medtronic Spinal
  • NuVasive Inc.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Wright Medical Group NV
  • Zimmer Biomet
  • 기타

제10장 시장의 향후 전망

KSM 18.09.28

The orthopedic devices market was valued at USD 39,585 million in 2020 and is expected to reach USD 51,425 million by 2026, registering a CAGR of about 4.9% over the forecast period.

In 2020, due to lockdown worldwide, private as well as public transport was stopped, which reduced road accidents and associated injuries. With that in healthcare facilities, the d treatment was shifted from orthopedic procedures to COVID-19 patients, which affected the market for the short term. particularly for the specialty hospitals. Along with that in a few regions, the orthopedic and small hospitals were shut down or their operations had been limited, and other hospitals were being converted to containment facilities and treatment wards for COVID-19 patients.

According to the research conducted by the CovidSurg Collaborative, a research network in 2020, it was found that orthopedic procedures were canceled most frequently, with 6.3 million orthopedic surgeries canceled worldwide over a 12-week period​ which had a short-term negative impact on the market.

The number of people went through joint replacement surgeries, such as total knee and hip replacement, has increased steadily and continues to rise owing to an increase in the elderly population. The rise in the musculoskeletal diagnoses and osteoporosis-related fractures is boosting the demand for orthopedic implants among elderly population. As per the report published by the Arthritis Research, United Kingdom, "The State of Musculoskeletal Health 2018", 17.8 million people were estimated to live with a musculoskeletal condition in the United Kingdom, which was around 28.9% of the total population. The above mentioned statistics indicates the number of orthopedic surgeries are increasing, which may lead to an rise in the demand for orthopedic implants. However, factors, such as stringent regulatory scenario, may hamper the growth of the market.

Key Market Trends

Join Reconstruction Segment is Expected to Grow at a Healthy Rate Over Forecast Period

With COVID-19 infections rising globally, there was a decline in both emergence and elective amputation surgeries owing to the current COVID-19 situation, which will decline the demand for orthopedic devices and is anticipated to adversely impact the market growth. For instance, according to the study published in the British Journal of Surgery, in May 2020, more than 580,000 planned surgeries in India might be canceled or delayed as a result of the COVID-19 pandemic, according to a study conducted by an international consortium in May 2020.

The joint reconstruction segment is anticipated to register high growth, due to the rising elderly population, the rising prevalence of osteoporosis and osteoarthritis, and the rising incidence of road accidents and sports injuries. For instance, according to UN report 2019, there were about 703 million people aged 65 years or over in the world in 2019. The number of older persons is anticipated to double to 1.5 billion in 2050. The rising elderly population is prone to several bones and joint disorders, which further fuels the market growth.

Additionally, companies are focusing on implementing strategies, such as mergers and acquisitions, product innovations, and recent developments, to gain a competitive advantage. For instance, in 2019, Smith & Nephew acquired Brainlab's orthopedic joint reconstruction business. This acquisition is expected to boost the development and adoption of digital technologies to enhance efficiency and outcomes during surgeries, which may positively impact the market's growth.

Asia-Pacific is Expected to Register the Fastest Growth Over the Forecast Period

Amid the pandemic, the procurement of equipment especially capital equipment has been on hold by a significant portion of hospitals performing amputation and orthopedic surgeries. All these factors are going to affect regional market growth.

The Pandemic has had ramifications for ways of working, of various surgical procedures including orthopedic surgeries. There are strict guidelines specific to each specialty that has to be implemented and followed, for orthopedic surgeons to be able to continue to provide safe and effective care to their patients during the COVID-19 pandemic.

For instance, in March 2020, in the United States, the National Association for the Advancement of Orthotics and Devices (NAAOP) issued an alert in which it was made clear that during the COVID-19 national emergency, state and local health authorities should consider orthotic and prosthetic practices as essential providers that must remain accessible to patients in need of orthotic and prosthetic care.

North America is expected to dominate the market, due to the direct presence of key regional players, a strong distribution network, and well-established healthcare infrastructure. Recent trends in the North America orthopedic devices market include the use of new polymer material and development of prosthetic device as per the functional need of patients.

Additionally, an increasing number of accidents and amputations in the country is also expected to drive the market for orthopedic devices in the United States. According to the Insurance Institute for Highway Safety (IIHS) and Highway Loss Data Institute (HLDI), they estimated that in 2017, there were 34,247 motor vehicle crashes in the United States, causing around 37,133 deaths.​

Also, according to the American Joint Replacement Registry, more than 498,817 primary hip replacements were performed during 2012 and 2018. Moreover, the average age of hip arthroplasty patients was 67.4 years.

Additionally, market players are focusing on developing novel orthopedic devices to satisfy the needs of the users. For instance, in September 2019, Active Implants' NUsurface Meniscus Implant breakthrough designation from USFDA. The adoption of such innovations to improve the efficiency of surgical procedures expected to boost the market studied in the region.

Competitive Landscape

The orthopedic devices market is highly fragmented. Market players focus on continuous product development and offering orthopedic devices at competitive prices, especially in developing countries. Minimally invasive orthopedic devices, which do not require repeat procedures, are expected to boost the number of procedures in the developed and developing regions.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support



  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Number of Large Joint Reconstruction Surgeries
    • 4.2.2 Growing Elderly Population Increases the Prevalence of Orthopedic Disorders
    • 4.2.3 Development of Bioabsorbable and Titanium Implants
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Scenario
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Application
    • 5.1.1 Hip Orthopedic Devices
    • 5.1.2 Joint Reconstruction
    • 5.1.3 Knee Orthopedic Devices
    • 5.1.4 Spine Orthopedic Devices
    • 5.1.5 Trauma Fixation Devices
    • 5.1.6 Dental Orthopedic Devices
    • 5.1.7 Other Applications
  • 5.2 By Geography
    • 5.2.1 North America
      • United States (By Application)
      • Canada (By Application)
      • Mexico (By Application)
    • 5.2.2 Europe
      • Germany (By Application)
      • United Kingdom (By Application)
      • France (By Application)
      • Italy (By Application)
      • Spain (By Application)
      • Rest of Europe (By Application)
    • 5.2.3 Asia-Pacific
      • China (By Application)
      • Japan (By Application)
      • India (By Application)
      • Australia (By Application)
      • South Korea (By Application)
      • Rest of Asia-Pacific (By Application)
    • 5.2.4 Middle-East and Africa
      • GCC (By Application)
      • South Africa (By Application)
      • Rest of Middle-East and Africa (By Application)
    • 5.2.5 South America
      • Brazil (By Application)
      • Argentina (By Application)
      • Rest of South America (By Application)


  • 6.1 Company Profiles
    • 6.1.1 Aesculap, Inc.
    • 6.1.2 AGIS Network, Inc.
    • 6.1.3 Amedica Corp.
    • 6.1.4 Arthrex, Inc.
    • 6.1.5 Boston Scientific Corporation
    • 6.1.6 DJO Global Inc.
    • 6.1.7 Exactech, Inc.
    • 6.1.8 Globus Medical Inc.
    • 6.1.9 Integra LifeSciences Corporation
    • 6.1.10 Johnson & Johnson
    • 6.1.11 Kinamed Incorporated
    • 6.1.12 Medtronic PLC
    • 6.1.13 NuVasive Inc.
    • 6.1.14 OrthAlign
    • 6.1.15 RTI Surgical
    • 6.1.16 Smith & Nephew PLC
    • 6.1.17 Stryker Corporation
    • 6.1.18 Wright Medical Group NV
    • 6.1.19 Zimmer Biomet


Back to Top
전화 문의